Anumana and Pfizer partner for cardiovascular disease detection

Related Articles
Anumana Named to Fast Company’s 2024 Next Big Things in Tech Awards
Award recognizes Anumana’s innovative AI-driven cardiovascular disease detection technologyNovember 19, 2024
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
HIT Consultant: Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm…December 16, 2022
AI researchers at Mayo Clinic use the Apple Watch to detect silent, weakening heart disease
FIERCE Biotech: Using simplified ECG data taken from an Apple Watch, researchers at the Mayo Clinic were able to use an artificial intelligence algorithm to spot people whose hearts may…May 02, 2022
Mayo Clinic helps launch two new companies for improved diagnostics
Mass Device: Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform…April 14, 2021


